Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-04-06
Summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. Data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future ovarian cancer patients.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-30
- Primary Completion
- 2025-04-30
- Completion
- 2026-04-30
More Related Trials
-
Women Surviving Ovarian Cancer
NCT00596349 ·Status: COMPLETED
-
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
NCT03019315 ·Status: UNKNOWN
-
Ovarian Cancer Patient Questionnaire on Genetic Testing
NCT00486707 ·Status: COMPLETED
-
Sexual Functioning After Primary Treatment of Ovarian Cancer
NCT00596544 ·Status: TERMINATED
-
M. D. Anderson Symptom Inventory - Ovarian Cancer
NCT01037751 ·Status: COMPLETED
-
Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
NCT06917469 ·Status: COMPLETED
-
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT01096394 ·Status: COMPLETED
-
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
NCT02973750 ·Status: COMPLETED
-
DOD Long-Term Survivors of Ovarian Cancer
NCT02321735 ·Status: UNKNOWN ·Phase: NA
-
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
NCT00084370 ·Status: WITHDRAWN ·Phase: NA
-
The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients
NCT00173394 ·Status: UNKNOWN
-
Chemotherapy-Related Toxicities In Ovarian Cancer Patients
NCT00508378 ·Status: COMPLETED
-
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265 ·Status: COMPLETED
-
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
NCT00445887 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
NCT00587093 ·Status: COMPLETED ·Phase: NA
-
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 ·Status: UNKNOWN
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Revealing Engagement Patterns Among Endometrial Cancer Patients
NCT05998798 ·Status: NOT_YET_RECRUITING
-
Fermented Wheat Germ Extract in Women With Ovarian Cancer
NCT02411565 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Healthy Volunteers Study
NCT06962059 ·Status: RECRUITING
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Research Study in Patients With Advanced Ovarian Epithelial Cancer
NCT00053235 ·Status: WITHDRAWN
-
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
NCT00191646 ·Status: COMPLETED ·Phase: PHASE3
-
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00897039 ·Status: UNKNOWN
-
Ovarian Reserve Testing in Female Young Adult Cancer Survivors
NCT01421095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA